Dapagliflozin for use in methods of treating heart failure with reduced ejection fractions

AL13785BActive Publication Date: 2026-10-29ASTRAZENECA AB
0 Cites 0 Cited by

Patent Information

Application Number
AL2026472
Authority / Receiving Office
AL · AL
Patent Type
Patents
Current Assignee / Owner
Filing Date
2026-08-04
Publication Date
2026-10-29
Estimated Expiration
2046-08-04
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.